Seastedt, K. P., Zare, A., Pezeshki, P. S., Salarikia, S. R., Zare, A., Ghalehtaki, R. (2026). Multi-cohort validation of a semaphorin prognostic signature to identify an immune- excluded subtype and therapeutic sensitivity in lung adenocarcinoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e20016